Abeona Therapeutics Inc.
ABEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$63,734 | -$54,188 | -$39,696 | -$84,936 |
| Dep. & Amort. | $2,907 | $3,198 | $4,577 | $4,464 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,628 | $4,768 | $3,051 | $8,916 |
| Change in WC | -$4,383 | -$1,788 | -$5,892 | -$18,263 |
| Other Non-Cash | $2,567 | $11,001 | -$5,523 | $24,154 |
| Operating Cash Flow | -$56,015 | -$37,009 | -$43,483 | -$65,665 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,446 | -$331 | -$130 | -$4,151 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$157,010 | -$51,636 | -$78,212 | -$20,163 |
| Inv. Sales/Matur. | $120,198 | $51,971 | $52,644 | $90,376 |
| Other Inv. Act. | $18 | $204 | $1,734 | $0 |
| Investing Cash Flow | -$39,240 | $208 | -$23,964 | $66,062 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20,000 | $0 | $0 | $0 |
| Stock Issued | $85,628 | $37,389 | $46,960 | $24,030 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,489 | -$332 | -$5 | $831 |
| Financing Cash Flow | $104,139 | $37,057 | $43,173 | $24,861 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,884 | $256 | -$24,274 | $25,258 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,811 | $14,555 | $38,829 | $13,571 |
| End Cash | $23,695 | $14,811 | $14,555 | $38,829 |
| Free Cash Flow | -$58,461 | -$37,340 | -$43,613 | -$69,816 |